دورية أكاديمية

Digital monitoring and management of patients with advanced or metastatic non-small cell lung cancer treated with cancer immunotherapy and its impact on quality of clinical care:interview and survey study among health care professionals and patients

التفاصيل البيبلوغرافية
العنوان: Digital monitoring and management of patients with advanced or metastatic non-small cell lung cancer treated with cancer immunotherapy and its impact on quality of clinical care:interview and survey study among health care professionals and patients
المؤلفون: Schmalz, O. (Oliver), Jacob, C. (Christine), Ammann, J. (Johannes), Liss, B. (Blasius), Iivanainen, S. (Sanna), Kammermann, M. (Manuel), Koivunen, J. (Jussi), Klein, A. (Alexander), Popescu, R. A. (Razvan Andrei)
بيانات النشر: JMIR Publications
سنة النشر: 2020
المجموعة: Jultika - University of Oulu repository / Oulun yliopiston julkaisuarkisto
مصطلحات موضوعية: advanced or metastatic non-small cell lung cancer, cancer immunotherapy, digital patient monitoring, drug- and indication-specific cancer immunotherapy module, eHealth, mHealth, patient-reported outcomes, quality of patient care, real-time symptom reporting, user experience
الوصف: Background: Cancer immunotherapy (CIT), as a monotherapy or in combination with chemotherapy, has been shown to extend overall survival in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). However, patients experience treatment-related symptoms that they are required to recall between hospital visits. Digital patient monitoring and management (DPMM) tools may improve clinical practice by allowing real-time symptom reporting. Objective: This proof-of-concept pilot study assessed patient and health care professional (HCP) adoption of our DPMM tool, which was designed specifically for patients with advanced or metastatic NSCLC treated with CIT, and the tool’s impact on clinical care. Methods: Four advisory boards were assembled in order to co-develop a drug- and indication-specific CIT (CIT+) module, based on a generic CIT DPMM tool from Kaiku Health, Helsinki, Finland. A total of 45 patients treated with second-line single-agent CIT (ie, atezolizumab or otherwise) for advanced or metastatic NSCLC, as well as HCPs, whose exact number was decided by the clinics, were recruited from 10 clinics in Germany, Finland, and Switzerland between February and May 2019. All clinics were provided with the Kaiku Health generic CIT DPMM tool, including our CIT+ module. Data on user experience, overall satisfaction, and impact of the tool on clinical practice were collected using anonymized surveys—answers ranged from 1 (low agreement) to 5 (high agreement)—and HCP interviews; surveys and interviews consisted of closed-ended Likert scales and open-ended questions, respectively. The first survey was conducted after 2 months of DPMM use, and a second survey and HCP interviews were conducted at study end (ie, after ≥3 months of DPMM use); only a subgroup of HCPs from each clinic responded to the surveys and interviews. Survey data were analyzed quantitatively; interviews were recorded, transcribed verbatim, and translated into English, where applicable, for coding and qualitative thematic ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
الإتاحة: http://urn.fi/urn:nbn:fi-fe202103117081Test
حقوق: info:eu-repo/semantics/openAccess ; © Oliver Schmalz, Christine Jacob, Johannes Ammann, Blasius Liss, Sanna Iivanainen, Manuel Kammermann, Jussi Koivunen, Alexander Klein, Razvan Andrei Popescu. Originally published in the Journal of Medical Internet Research (http://www.jmir.orgTest), 21.12.2020. This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0Test/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.orgTest/, as well as this copyright and license information must be included. ; https://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.F2A4D73E
قاعدة البيانات: BASE